Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer
Adam C. Mueller, Miles Piper, Andrew Goodspeed, et al.
Cancer Research (2021) Vol. 81, Iss. 12, pp. 3255-3269
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
Qingmiao Shi, Chen Xue, Yifan Zeng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 81
Eph receptors and ephrins in cancer progression
Elena B. Pasquale
Nature reviews. Cancer (2023) Vol. 24, Iss. 1, pp. 5-27
Open Access | Times Cited: 49
Simultaneous targeting of PD-1 and IL-2Rβγ with radiation therapy inhibits pancreatic cancer growth and metastasis
Miles Piper, Maureen Hoen, Laurel B. Darragh, et al.
Cancer Cell (2023) Vol. 41, Iss. 5, pp. 950-969.e6
Open Access | Times Cited: 48
Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma
Lingxi Jiang, Jiejie Qin, Yuting Dai, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 749-761
Closed Access | Times Cited: 24
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
Zhipeng Cao, Sadia Quazi, Sakshi Arora, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 6
Efficacy of Neoadjuvant Radiotherapy After Chemotherapy and the Optimal Interval from Radiotherapy to Surgery for Borderline Resectable and Resectable Pancreatic Cancer
Won‐Gun Yun, Yoon Soo Chae, Youngmin Han, et al.
Annals of Surgical Oncology (2025) Vol. 32, Iss. 4, pp. 2819-2829
Open Access | Times Cited: 2
The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth
Paul Manoukian, Maarten F. Bijlsma, Hanneke W.M. van Laarhoven
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 61
Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma
Ben George, Olga Kudryashova, Andrey Kravets, et al.
Gastroenterology (2024) Vol. 166, Iss. 5, pp. 859-871.e3
Closed Access | Times Cited: 12
Deciphering the Biological Effects of Radiotherapy in Cancer Cells
Lu Zhou, Xueting Zheng, Chenghe Ding, et al.
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1167-1167
Open Access | Times Cited: 28
New insights into the function and pathophysiology of the ectodomain sheddase A Disintegrin And Metalloproteinase 10 (ADAM10)
David P. Rosenbaum, Paul Säftig
FEBS Journal (2023) Vol. 291, Iss. 13, pp. 2733-2766
Open Access | Times Cited: 22
Direct interaction of platelet with tumor cell aggravates hepatocellular carcinoma metastasis by activating TLR4/ADAM10/CX3CL1 axis
Jiahui Gao, Aodi He, Lu-Man Liu, et al.
Cancer Letters (2024) Vol. 585, pp. 216674-216674
Closed Access | Times Cited: 7
Targeting Fibrosis: The Bridge That Connects Pancreatitis and Pancreatic Cancer
Can Huang, Juan Iovanna, Patricia Santofimia‐Castaño
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4970-4970
Open Access | Times Cited: 37
Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pancreatic Adenocarcinoma
Miles Piper, Benjamin Van Court, Adam C. Mueller, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 5, pp. 1013-1026
Open Access | Times Cited: 36
Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis
Atsushi Oba, Yan‐Dong Wu, Kathryn Colborn, et al.
British journal of surgery (2022) Vol. 109, Iss. 5, pp. 450-454
Closed Access | Times Cited: 26
Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer
Huiru Zhang, Long‐Yun Ye, Xianjun Yu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment
Stavros P. Papadakos, Nikolaos Dedes, Nikolina Gkolemi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 3015-3015
Open Access | Times Cited: 11
Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo
Ehsan Bahrami, Jan Philipp Schmid, Vindi Jurinović, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Targeting the pancreatic tumor microenvironment by plant-derived products and their nanoformulations
Mohamed J. Saadh, Mohammed Ahmed Mustafa, H. Malathi, et al.
Medical Oncology (2024) Vol. 41, Iss. 8
Closed Access | Times Cited: 4
Unraveling the underlying mechanisms of cancer stem cells in therapeutic resistance for optimizing treatment strategies
Yunhan Tan, Siyuan Qin, Zhe Zhang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access
SP1/ADAM10/DRP1 axis links intercellular communication between smooth muscle cells and endothelial cells under hypoxia pulmonary hypertension
Hongyan Li, Yi Liu, Xianbao Shi, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167720-167720
Closed Access
Role of radiotherapy in surgical approaches to pancreatic cancer treatment: A narrative review
Satoshi Yasuda, Minako Nagai, Kota Nakamura, et al.
Annals of Gastroenterological Surgery (2025)
Open Access
High local failure rates despite high margin‐negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi‐agent chemotherapy
Colin Hill, Shuchi Sehgal, Wei Fu, et al.
Cancer Medicine (2022) Vol. 11, Iss. 7, pp. 1659-1668
Open Access | Times Cited: 17
Local radiotherapy for murine breast cancer increases risk of metastasis by promoting the recruitment of M-MDSCs in lung
Zhengzheng Zhang, Zhiyan Yao, Zimeng Zhang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
ADAM22 acts as a novel predictive biomarker for unfavorable prognosis and facilitates metastasis via PI3K/AKT signaling pathway in nasopharyngeal carcinoma
Kaixiong Xu, Ping Jiang, Zui Chen, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155264-155264
Open Access | Times Cited: 3
The preclinical gap in pancreatic cancer and radiotherapy
Mathias Tesson, Jennifer P. Morton
Disease Models & Mechanisms (2024) Vol. 17, Iss. 7
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top